News from the healthcare data industry
October 31, 2023 08:05 AM Eastern Daylight Time PALO ALTO, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Flatiron Health, a leading healthtech company...
Dec 09, 2022 | staff reporterSave for later NEW YORK — Guardant Health said on Thursday that it has signed an agreement to develop its Guardant360 CDx blood-based liquid biopsy assay as...
Presentations to highlight role of liquid biopsy tests and real-world data to identify biomarkers, predict patient response to therapy, and detect resistance mechanisms in late-stage cancers September 06, 2022 08:05 AM...
Agreement will leverage GuardantINFORM real-world evidence platform to advance development efforts for core cancer indications August 31, 2022 08:05 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq:...
August 08, 2022 06:15 AM Eastern Daylight Time PALO ALTO, Calif., & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Guardant Health Inc. (Nasdaq: GH), a leading precision oncology company, and Blueprint Medicines Corporation (Nasdaq: BPMC)...
Presentations to highlight role of liquid biopsy tests and real-world data in identifying resistance mechanisms to therapy, demonstrating impact of specific mutations on treatment efficacy, and informing therapeutic strategies in...
By Brittany Wade June 2, 2022 | Innovation Practices Award–Extracting high-quality data from clinical records can be time-consuming and costly, primarily when manual abstractors are tasked with mining complex, unstructured, and...
April 11, 2022 By Bio-IT World Staff April 11, 2022 | Bio-IT World today announced the 2022 Innovative Practices Awards winners. Four grand prize awards were granted to AstraZeneca, Guardant Health with IQVIA,...
April 04, 2022 08:05 AM Eastern Daylight Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with Epic, the nation’s most...
March 18, 2022 — Illumina has hit Guardant Health with a lawsuit alleging Guardant and its founders Helmy Eltoukhy and AmirAli Talasaz misappropriated Illumina’s trade secrets and breached a contract over...